Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 1, 1998Histopathology

Gains and losses of CD44 expression during breast carcinogenesis and tumour progression

View Full Paper
Ask AI
Bookmark
Share

Authors

ÁBÁgnes BánkfalviEssen University HospitalHTHJ TerpeKlinikum LeverkusenDBDirk BreukelmannUniversity of Münster

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Bánkfalvi et al. (1998) studied this question.

synapsesocial.com/papers/6a71019e75498292b70a7de4https://doi.org/10.1046/j.1365-2559.1998.00472.x
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1CD44 isoforms correlate with cellular differentiation but not with prognosis in human breast cancer1995 · 157 citations
  2. 2Expression of CD44 isoforms in renal cell tumors : positive correlation to tumor differentiation1996 · 84 citations
  3. 3Coexpression of CD44 variant (v10/ex14) and CD44S in human mammary epithelial cells promotes tumorigenesis1997 · 66 citations
  4. 4CD44 variant isoforms in non-Hodgkin's lymphoma: a new independent prognostic factor1995 · 227 citations